2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
|
|
- CAS-Nr.
- 134790-39-9
- Englisch Name:
- 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
- Synonyma:
- Gemcitabine alpha-Anomer;2,2-DIFLOURO-2-DEOXYCYTIDINE-3,5-DIBENZOATE;2’,2’-Difluoro-2’-deoxycyodine-3’,5’-dibenzoate;(2R,3R,5R)-5-(4-aMino-2-oxopyriMidin-1(2H)-yl)-2-(benzoyloxyMethyl)-4,4-difluorotetrahydrofuran-3-yl benzoate;GCTB-T9;T9 of Gemcitabine;Chloropurine riboside;GeMcitabine InterMediate 9;Gemcitabine T9 Intermediate;(2R,3R,5R)-5-(4-amino-2-oxopyrimidin
- CBNumber:
- CB1855625
- Summenformel:
- C23H19F2N3O6
- Molgewicht:
- 471.41
- MOL-Datei:
- 134790-39-9.mol
|
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate Eigenschaften
- Schmelzpunkt:
- 229-232°C
- Siedepunkt:
- 608.4±65.0 °C(Predicted)
- Dichte
- 1.45±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,2-8°C
- L?slichkeit
- DMSO
- Aggregatzustand
- Solid
- pka
- 4.26±0.10(Predicted)
- Farbe
- Off-White
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Tan Solid
Verwenden
A (-anomer) intermediate of Gemcitabine; antitumor compound
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 185)Lieferanten
134790-39-9()Verwandte Suche:
- 2',2'-difluoro-2'-deoxycytidine-3',5'-dibenzoate
- Cytidine, 2'-deoxy-2',2'-difluoro-, 3',5'-dibenzoate
- 2'-Deoxy-3',5'-di-O-benzoyl-2',2'-difluorocytidine, >=97%
- 2-DEOXY-2,2-DIFLUORO-35-BIS-O-BENZOYLEYTIDINE MONOHYDROCHLORIDE
- T9 of Gemcitabine
- 2'-deoxy-2,2'-difluoro-3,5-dibenzyl-cytidine
- 2',2'-Difluoro-2'-deoxycyodine-3',5'–dibenzoate ( or its salt)
2'-deoxy-2',2'-difluoro-3',5'-di-O-benzoates-cytidine (or its salt)
- Cytidine, 2'-deoxy-2',2'-difluoro-, 3',5'-dibenzoate (9CI)
- 2’-Deoxy-2’,2’-difluoro-3’,5’-bis-O-benzoylcytidine
- 2’-Deoxy-3’,5’-di-O-benzoyl-2’,2’-difluorocytidine
- Chloropurine riboside
- 3',5'-Di-O-benzoyl-2'-deoxy-2',2'-difluorocytidine
- GeMcitabine InterMediate 9
- T9, 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
- 2'-Deoxy-2',2'-difluro-3'5'-bis-O-benzoylcytidine
- 2'-Deoxy-2',2'-difluorocytidine-3',5'-dibenzoate, 1-(3,5-Bis-O-benzoyl-2-deoxy-2,2-difluoro-beta-D-ribofuranosyl)cytosine
- 3',5'-Bis-O-benzoyl-2'-deoxy-2',2'-difluorocytidine
- [(2R,3S,5R)-5-(4-aMino-2-oxo-1,2-dihydropyriMidin-1-yl)-3-(benzoyloxy)-4,4-difluorooxolan-2-yl]Methyl benzoate
- 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (Gemcitabine impurity)
- 3',5'-Di-O-benzoyl-2',2'-difluoro-2'-deoxy cytidine
- (2R,3R,5R)-5-(4-amino-2-oxopyrimidin
- Gemcitabine impurity 4/2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate
- 2-[[5-(4-amino-2-oxo-1-pyrimidinyl)-3-(2-carboxylatophenyl)-4,4-difluoro-3-hydroxy-2-oxolanyl]-hydroxymethyl]benzoate
- 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate USP/EP/BP
- (2R,3R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
- Gemcitabine T9 Intermediate
- (2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-(benzoyloxy)-4,4-difluorooxolan-2-yl]methyl benzoate
- 2’,2’-Difluoro-2’-deoxycyodine-3’,5’-dibenzoate
- (2R,3R,5R)-5-(4-aMino-2-oxopyriMidin-1(2H)-yl)-2-(benzoyloxyMethyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
- Gemcitabine alpha-Anomer
- 2,2-DIFLOURO-2-DEOXYCYTIDINE-3,5-DIBENZOATE
- 2',2'- difluoro -2'- deoxycytosine nucleoside -3',5'- dibenzoate
- GCTB-T9
- 2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate (T9)
- 134790-39-9
- C23H19F2N3O6
- Amines
- Bases & Related Reagents
- Heterocycles
- Nucleotides
- API intermediates